Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2003
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317453A1 Isoxazoles and their use as inhibitors of erk
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317443A2 Chemokine receptor binding heterocyclic compounds
06/11/2003EP1317433A2 Inhibitors of glycogen synthase kinase 3
06/11/2003EP1317428A1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317421A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317420A1 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317417A2 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
06/11/2003EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3
06/11/2003EP1317310A1 Use of serum response factor (srf) modulator for treating srf related diseases
06/11/2003EP1317284A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
06/11/2003EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
06/11/2003EP1317276A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects
06/11/2003EP1317265A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
06/11/2003EP1317259A2 Prevention of acute sinusitis and sinus attack
06/11/2003EP1131065B1 Dialkylfumarates for the treatment of autoimmune diseases
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/11/2003EP0954325B1 Method for the specific immunoadsorption of selected pathogenic factors in the treatment of aids
06/11/2003EP0750511B1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
06/11/2003EP0662086B1 Protein l and hybrid proteins thereof
06/11/2003CN1423704A Process for producing tripeptides
06/11/2003CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex
06/11/2003CN1423657A Inter feron-alpha induced gene
06/11/2003CN1423647A Beta-alanine derivatives and their use as receptor antagonists
06/11/2003CN1423646A Hetero cyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
06/11/2003CN1423645A 维他命d类似物 Vitamin d analogues
06/11/2003CN1423633A Azetidine derivatives, preparation thereof and pharmaceutical compositions
06/11/2003CN1423627A 维生素d类似物 Vitamin d analogues
06/11/2003CN1423563A Pancreatic stem cells and their use in transplantation
06/11/2003CN1423523A Human ex vivo immune system
06/11/2003CN1422888A Nucleic compound and production method thereof, and its use in the preparation of immune formulation
06/11/2003CN1422862A 3,6 branched manno oligose structure used as medicine and its preparation method
06/11/2003CN1422859A Reaction method of biological alkali, reaction product and use thereof
06/11/2003CN1422849A 吲唑衍生物 Indazole derivative
06/11/2003CN1422643A Oral pill for treating lupus erythematosus
06/11/2003CN1111071C Vaccines containing saponin and sterol
06/11/2003CN1111068C Strong anti-oxidative composite capsule of grape seed extract OPC and its production method
06/10/2003US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide
06/10/2003US6576758 Nucleic acid constructs containing hybrid promoters
06/10/2003US6576658 Compositions and uses of dictyostatin compounds
06/10/2003US6576648 Compound with growth hormone releasing properties
06/10/2003US6576644 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
06/10/2003US6576630 Compounds and compositions as protease inhibitors
06/10/2003US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions
06/10/2003US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis
06/10/2003US6576268 Biologically active fraction of vegetable melanin, process for its production and its use
06/10/2003US6576260 Sustained-release form of administration containing tramadol saccharinate
06/10/2003US6576259 Sustained release formulations containing tacrolimus
06/10/2003US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group
06/10/2003US6576236 Contacting T cell which expresses cytokine receptor gamma chain with anti-gamma chain antibody which binds to and transduces signal via gamma chain such that T cell responsiveness is stimulated
06/10/2003CA2234208C Influenza vaccine
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2054619C Aminocoumaran derivatives, their production and use
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/06/2003CA2436943A1 Hydantoin compounds useful as anti-inflammatory agents
06/05/2003WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases
06/05/2003WO2003046578A2 Method for the assessment and prognosis of sarcoidosis
06/05/2003WO2003046185A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003WO2003046135A2 Osteopontin-related compositions and methods
06/05/2003WO2003046124A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003WO2003046012A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation
06/05/2003WO2003046011A1 Antigen presenting cell targeting conjugate an antigen presenting cell contacted with such conjugate their use for vaccination or as medicament and methods for their production or generation
06/05/2003WO2003046008A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003WO2003045979A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
06/05/2003WO2003045978A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003WO2003045974A2 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003WO2003045968A1 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
06/05/2003WO2003045951A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045943A1 Quinazoline compounds with therapeutic use
06/05/2003WO2003045938A1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23
06/05/2003WO2003045922A1 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
06/05/2003WO2003045906A2 Synthesis of 2-cyanoziridine-1-carboxamide
06/05/2003WO2003045523A2 Therapeutic coating for an intravascular implant
06/05/2003WO2003045456A1 Process for coating a surface of a stent
06/05/2003WO2003045437A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003WO2003045414A2 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections
06/05/2003WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/05/2003WO2003045393A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003WO2003045391A1 Pharmaceutical formulations comprising an immune response modifier
06/05/2003WO2003045386A1 Benzothiazole derivatives
06/05/2003WO2003045385A1 Benzothiazole derivatives
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045373A1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045364A2 Use of quinazolines to treat t-cell mediated diseases
06/05/2003WO2003045363A2 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
06/05/2003WO2003045362A2 Treatment of th1 dominated immunological disease states with non-endogenous gestagen compounds
06/05/2003WO2003045338A1 Compositions comprising phenyl-glycine derivatives
06/05/2003WO2003045335A2 Stem cell screening and transplantation therapy for hiv infection
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045331A2 Formulations for oral administration of cromolyn sodium
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
1 ... 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 ... 1172